Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
The stability of taxol (NSC-125973) in various diluents and containers was determined, and the extent of leaching of di(2-ethylhexyl) phthalate (DEHP) from polyvinyl chloride (PVC) bags caused by the taxol formulation was measured. A taxol formulation consisting of a 6-mg/mL solution of taxol in 50% polyoxyethylated castor oil and 50% dehydrated ethanol was added to 50- and 100-mL glass bottles, PVC infusion bags, and polyolefin containers containing 5% dextrose injection or 0.9% sodium chloride injection to give initial nominal taxol concentrations of 0.3, 0.6, 0.9, and 1.2 mg/mL. The containers were maintained at 20-23 degrees C for 12-24 hours. Samples were assayed by stability-indicating high-performance liquid chromatography, and clarity was determined visually. An experiment was run to ascertain whether DEHP would leach from a PVC administration set during a simulated infusion. There was no substantial loss of taxol over 24 hours. Filtration through a membrane resulted in no loss of taxol. All the solutions initially appeared hazy. Solutions stored in PVC bags became more hazy with time than solutions stored in glass or polyolefin containers. The haze seen in PVC bags was traced to leaching of DEHP. Agitation had no effect on the extent of leaching. Leaching was also seen during simulated delivery through PVC administration sets. No DEHP was detected when solutions were stored in glass or polyolefin containers and infused through polyethylene-lined sets. At the dilutions studied, taxol was visually and chemically stable for up to 24 hours.(ABSTRACT TRUNCATED AT 250 WORDS)
Waugh
W N
WN
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66045.
Trissel
L A
LA
Stella
V J
VJ
D000470:Alkaloids / Q000032:analysis / Q000737:chemistry*; D000972:Antineoplastic Agents, Phytogenic / Q000032:analysis / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D004051:Diethylhexyl Phthalate / Q000032:analysis / Q000737:chemistry*; D004344:Drug Incompatibility; D004355:Drug Stability; D004356:Drug Storage; D005947:Glucose; D007263:Infusions, Parenteral / Q000295:instrumentation; D017239:Paclitaxel; D011143:Polyvinyl Chloride / Q000032:analysis / Q000737:chemistry*; D012965:Sodium Chloride; D012996:Solutions; D013997:Time Factors
D000470:Alkaloids; D000972:Antineoplastic Agents, Phytogenic; D012996:Solutions; D012965:Sodium Chloride; D011143:Polyvinyl Chloride; D004051:Diethylhexyl Phthalate; D005947:Glucose; D017239:Paclitaxel